Corrigendum to Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins > Nutr Metab Cardiovasc Dis. 2022 Sep;32(9):2255-2263
Nutr Metab Cardiovasc Dis
.
2023 Apr;33(4):920-921.
doi: 10.1016/j.numecd.2023.02.006.
Epub 2023 Mar 21.
Authors
Raffaella Buzzetti
1
,
Gian Paolo Fadini
2
,
Antonio Nicolucci
3
,
Monica Larosa
4
,
Maria Chiara Rossi
5
,
Domenico Cucinotta
6
;
RESTORE-2 Study Group
Affiliations
1
Department of Experimental Medicine, Sapienza University of Rome, Italy.
2
Department of Medicine, University of Padova, Padua, Italy.
3
CORESEARCH - Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy. Electronic address: nicolucci@coresearch.it.
4
Medical Affairs, Sanofi Milan, Italy.
5
CORESEARCH - Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy.
6
Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
PMID:
36948942
DOI:
10.1016/j.numecd.2023.02.006
No abstract available
Publication types
Published Erratum